Meridian Investment Counsel Inc. Viatris Inc Transaction History

Meridian Investment Counsel Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $292,372 - $355,006	-24,183 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$13.25 - $15.13 $36,159 - $41,289	-2,729 Reduced 10.14%	24,183 $328,000
Q2 2021 Jul 23, 2021	SELL	$12.97 - $16.15 $23,968 - $29,845	-1,848 Reduced 6.43%	26,912 $385,000
Q1 2021 May 03, 2021	BUY	$13.59 - $18.54 $203,306 - $277,358	14,960 Added 108.41%	28,760 $402,000
Q4 2020 Feb 03, 2021	BUY	$14.3 - $18.74 $197,340 - $258,611	13,800 New	13,800 $259,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

Stay updated on Meridian Investment Counsel Inc. with notifications on news.